A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1
Clinical trial NCT06698003 · RECRUITING
Trial details
- NCT number
- NCT06698003
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-15
- Primary completion
- 2029-11-15
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.